This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bree Leigh Richey: Innovator in Cancer Treatment
Introduction
Bree Leigh Richey is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds.
Latest Patents
Richey holds a patent for KRas G12C inhibitors. This patent provides compounds that are designed to treat patients with cancer. The compounds include pharmaceutically acceptable salts and methods for their use, showcasing her commitment to advancing medical science.
Career Highlights
Bree Leigh Richey is associated with Eli Lilly and Company, a leading pharmaceutical firm. Her work at Eli Lilly focuses on developing groundbreaking treatments that can improve patient outcomes in oncology.
Collaborations
Richey collaborates with esteemed colleagues such as David Michael Hyman and Gregory Lawrence Lackner. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Bree Leigh Richey is a trailblazer in the field of cancer treatment, with her innovative patents and collaborations paving the way for future advancements in medicine. Her work exemplifies the impact of dedicated inventors in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile